Editorial

                     


May 20, 2013

Playing the IPO Market: Lessons From Facebook’s Disastrous IPO
Filed under: Expert Commentary,IPOHenry Truc @ 7:00 am

In this week’s interview with Francis Gaskins, Equities.com takes a look at the IPO landscape one year after Facebook’s (FB) debut. We also discuss some of the best recent performers and upcoming offerings that investors should be paying attention to. Gaskins has been recognized by major financial media outlets such as Forbes, CNBC, Bloomberg, and many othersas one of the best resources for the IPO industry available today. Gaskins is a highly sought-after expert for his insights and opinions as an IPO analyst. Readers can see his previous weekly interviews with Equities.com here. EQ: Last week, we discussed Ambit Biosciences (AMBI), which cut its IPO price pretty drastically the day before it began trading to $8 per share. You advised before the IPO that it was probably a good idea to stay away from this one for now. Were you surprised by how poorly it actually ended up performing? (more)…

May 13, 2013

Playing the IPO Market: Knowing When to Look Under the Hood
Filed under: Expert Commentary,IPOHenry Truc @ 10:45 am

In this week’s interview with Francis Gaskins, Equities.com takes a look at a few interesting names coming down the pipeline, and a few recent notable debuts. One interesting name that may have investors excited is Sprouts Farmers Market, LLC, which filed last week, but considering the track record of the firm behind it, investors may want to take a closer examination at how ripe that opportunity may actually be for the picking. EQ: As we discussed in our last interview, Thursday was a very busy day for IPOs, with 7 new listings. There were 11 total for the week. Which ones stood out to you the most? Gaskins: Quintiles Transnational Holdings (Q) was the biggest at $800 million on the IPO with a market capitalization of around $5 billion.  It’s dominant in its field and provides biopharma development services worldwide.  (more)…

May 6, 2013

Playing the IPO Market: Investors Prepare for a Flurry of New Listings
Filed under: Expert Commentary,IPOHenry Truc @ 11:00 am

In this week’s interview with Francis Gaskins, President and Editor of IPOdesktop.com, we take a look at the week ahead for upcoming IPOs, and discuss which names stick out as attractive opportunities or to just flat-out avoid. We also get his take on the recent rumblings of Twitter revisiting the prospects of going public, and how the situation shares some similarities of hot tech IPOs of the past. Gaskins has been recognized by major financial media outlets such as Forbes, CNBC, Bloomberg, and many othersas one of the best resources for the IPO industry available today. Gaskins is a highly sought-after expert for his insights and opinions as an IPO analyst. Readers can see his previous weeklyinterviews with Equities.com here. EQ: On Thursday, shares of ING spin-off Voya Financial (VOYA) began trading on the NYSE. This was the second largest offering so far this year, and one that you liked (more)…

April 29, 2013

Playing the IPO Market: Knowing Which Indicators To Use for Finding Good IPOs
Filed under: Expert Commentary,IPOHenry Truc @ 7:30 am

In this week’s interview with Francis Gaskins, President and Editor of IPOdesktop.com, we discuss how investors of different kinds typically participant in IPOs, and what indicators should be viewed closely when examining opportunities. Gaskins has been recognized by major financial media outlets such as Forbes, CNBC, Bloomberg, and many othersas one of the best resources for the IPO industry available today. Gaskins is a highly sought-after expert for his insights and opinions as an IPO analyst. Readers can see his previous weekly interviews with Equities.com here. EQ: We’ve discussed how hot the IPO market has been during the first four months of 2013, especially when comparing the numbers from 2012. What are some of the reasons driving this renewed interest in this market? Gaskins: The general stock market has been in an upswing. When that happens the IPO market is kind of like the tail following the dog, and (more)…

April 22, 2013

Playing the IPO Market: Is Fairway Group the Next IPO Disaster?
Filed under: Expert Commentary,IPOHenry Truc @ 6:45 am

Last week saw a mixed bag of IPOs on the market, with several stronger performers, and others not so much. Meanwhile, one particularly name may be a solid candidate for joining the ranks of Groupon (GRPN), Facebook (FB), and other unfortunate names that will go down as some of the worst IPOs in history. Which company is it? In this week’s interview with Francis Gaskins, President and Editor of IPOdesktop.com, we discuss some solid debuts last week, one setting up for a fall sooner or later, and what’s in store for this week’s IPO slate. Gaskins has been recognized by major financial media outlets such as Forbes, CNBC, Bloomberg, and many othersas one of the best resources for the IPO industry available today. Gaskins is a highly sought-after expert for his insights and opinions as an IPO analyst. Readers can see his previous weekly interviews with Equities.com here. EQ: (more)…

April 15, 2013

Playing the IPO Market: When to Flip ‘Em and When to Hold ‘Em
Filed under: Expert Commentary,IPOHenry Truc @ 12:10 pm

The IPO market saw some strong debuts last week with Taylor Morrison Home Corp. (TMHC), Rally Software Development Corp. (RALY), and Chimerix, Inc. (CMRX) enjoying successful first days. In this week’s interview with Francis Gaskins, President and Editor ofIPOdesktop.com, we discuss why investors were chomping at the bit for these new issuers, and what companies are in store for this week’s IPO slate. Gaskins has been recognized by major financial media outlets such as Forbes, CNBC, Bloomberg, and many othersas one of the best resources for the IPO industry available today. Gaskins is a highly sought-after expert for his insights and opinions as an IPO analyst. Readers can see his previous weekly interviews with Equities.com here. EQ: Taylor Morrison Home Corp. (TMHC) completed its IPO this week, and is up almost 10 percent from its debut price of $22 per share. This was one that you seemed to like (more)…

April 4, 2013

Playing the IPO Market: Exclusive Interview with Expert Francis Gaskins
Filed under: Expert Commentary,IPOHenry Truc @ 10:00 am

While high-profile initial public offerings reached a frenzied pitch the past two years, investors may have felt a bit burnt by buying into over-hyped businesses with potential but lacking sound fundamental. One particular area where this may have been especially true was the blazing hot social media space. But as the buzz of new listings started to fade, the IPO market has somewhat quietly made a huge comeback. To get a better grasp on the new opportunities in this space, Equities.com spoke with Francis Gaskins, President and Editor of IPOdesktop.com, which has been recognized by major financial media outlets such as Forbes, CNBC, Bloomberg, and many others as one of the best resources for the IPO industry available today. Gaskins is a highly sought-after expert for his insights and opinions as an IPO analyst. In this week’s interview, we discuss (more)…

March 20, 2013

Model N Soars Over 30 percent on IPO
Filed under: Equities Editor's Desk,Healthcare,IPO,Technology — Michael Teague @ 10:13 am

Model N (MODN), a Northern California software outfit that provides revenue management services for healthcare and technology companies, is having a stellar IPO day.  Starting off with a price of $15.50, the stock has soared 34.65 percent, currently trading at $20.87. The company raised about $104 million, and currently has a market cap of around $445 million. Zack Rinat, the company’s CEO and founder, sees a role for management software that extends beyond the traditional cost-cutting and process-automation needs for things like human capital management in human resource departments, sales and marketing for customer relationship management, and finance for enterprise resource planning.  “Keep in mind that customers lose tens of billions each year by leaving money on the table because they do not effectively manage pricing, rebates/incentives and contracting,” he said in an interview on Wednesday morning. The other part of the (more)…

March 8, 2013

A Look at the Tech IPO Class of 2011 as Pandora and Groupon CEOs Resign
Filed under: Equities Editor's Desk,IPO,Technology — Michael Teague @ 6:35 am

The internet radio company Pandora (P) held its initial public offering in 2011, along with a groups of internet businesses. Revenue for the quarter was $125.1 million, a non-GAAP loss of $0.04 per share, but topping analyst expectations of $122.81 million, or $0.05 cents per share. The Q4 revenue figure represents a 54 percent increase on the same period the year prior. More impressive, however, was the growth in revenue from mobile devices: $80.3 million in Q4, an increase of 111 percent on the year prior. Listeners clocked in a total of 4.05 billion hours, up 53 percent from the year before. The company claims to be the largest radio station in most American markets, with 67 million monthly listeners, or eight percent of all radio listening. The company closed Thursday edging just upwards of 0.50 percent to $11.73 per (more)…

November 14, 2012

Stormy Conditions Causing Delays in Initial Public Offerings
Filed under: Equities Editor's Desk,Healthcare,IPO — Andrew Klips @ 7:00 am

Radius Health Inc. (RDUS) said Wednesday that it is postponing its initial public offering, citing market conditions.  The company planned its offering for today to list on the Nasdaq Global Market under the ticker “RDUS.”  In October, the pharmaceutical company reported that it expected its IPO of 6.5 million shares to be priced between $8.50 and $10.50 per share.  At the midpoint of the range, Radius would have a fully-diluted market capitalization of about $300 million. The Cambridge, Massachusetts company is primarily focused on developing new therapeutics for the treatment of osteoporosis and other women’s health conditions.  In December 2011, Radius raised $91 million in venture funding with a portion of the raise dedicated towards its phase III clinical trials of its lead drug candidate, BA058, an injectable which is said to stimulate rapid bone formation in osteoporosis patients.  Since (more)…

Older Posts »

Sector News



Market Overview

Symbol Last Change % Change
DJIA15,303.108.600.06
NASDAQ3,459.14-0.2735-0.01
S&P 500 EOD1,649.64-0.87-0.05
10yr Trsy20.110.110.55
Data is delayed 20 mins/EOD

Uncommon Wisdom with Fisher Investments

Fisher Investments
Japanese policymakers largely understand what their Chinese counterparts don’t—encouraging private firms to invest more and as they see fit is the best way to goad sustainable economic growth.

Behind the Frontlines with Mauldin Economics

John Mauldin
There is bipartisan legislation making its way through Congress that is a huge step in dealing with too big to fail. Taxpayers and investors should be paying attention.

Richard Suttmeier of ValuEngine

Richard Suttmeier
The daily chart for Kinross Gold shows rising momentum with the stock above its 21-day simple moving average but below its 50-day and 200-day simple moving averages.